Skip to content
Screener

LeMaitre Vascular LMAT Share Buybacks

Share Buybacks at other companies

ITG
Integer HoldingsITGR
$50M
Abbott logo
AbbottABT
$1.05B+17,317%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$0
Edwards Lifesciences logo
Edwards LifesciencesEW
$421.8M+63.1%
Medtronic logo
MedtronicMDT
$435M+58.8%
IAR
Integra LifeSciencesIART
$55.25K-97.8%

Other financials

Income statement

See full
Revenue$70.4M+9.6%
Gross profit$50.8M+12.9%
Operating income$20.4M+26.4%
Net income$17.1M+23.7%
EPS (diluted)$0.74+23.3%

Balance sheet

See full
Cash & equivalents$26.6M-2.0%
Total debt$21.2M+19.7%
Total equity$420.3M+15.9%
Total assets$640.5M+10.9%

Cash flow

See full
Operating cash flow$16.0M-21.3%
CapEx$2.3M+72.4%
Free cash flow$13.7M-28.0%

Valuation

See full
Market cap$1.85B-12.4%
Enterprise value$1.84B-12.3%
P/E28.1×-16.6×
P/S-2.0×

Profitability

See full
Gross margin72.9%+3.8pp
Operating margin29.5%+6.1pp
Net margin25%+4.9pp
FCF margin28.1%+5.8pp

Returns & leverage

See full
Return on equity16.8%+3.0pp
Debt / equity0.1×0.0×
Current ratio16.3×+2.4×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:30 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333762
Line itemFor the six months ended / June 30, 2026For the six months ended / June 30, 2025
Financing activities
Proceeds from stock option exercises3,7283,072
Deferred payments for acquisitions(95)(1,433)
Payment of withholding taxes in connection with net settlement of equity awards(477)(605)
Common stock cash dividend paid(11,427)(9,037)
Net cash used in financing activities(8,271)(8,003)
Effect of exchange rate changes on cash and cash equivalents(207)909
Net (decrease) increase in cash and cash equivalents(1,619)1,567

Item 1. Financial Statements

FAQ

What is LeMaitre Vascular's share buybacks?
LeMaitre Vascular (LMAT) reported share buybacks of $17K in Q2 2026.
How has LeMaitre Vascular's share buybacks changed year-over-year?
LeMaitre Vascular's share buybacks increased by 325.0% year-over-year, from $4K to $17K.
What is the long-term trend for LeMaitre Vascular's share buybacks?
Over 3 years (2022 to 2025), LeMaitre Vascular's share buybacks has grown at a 41.6% compound annual growth rate (CAGR), from $642K to $1.82M.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Ask your AI about LeMaitre Vascular's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude